Peripheral nerve and spinal cord injuries are potentially devastating traumatic conditions
with major consequences for patients' lives. Severe cases of these conditions are currently …

Spinal cord injury (SCI), a serious public health issue, most likely occurs in previously
healthy young adults. Current therapeutic strategies for SCI includes surgical …

Allogeneic cell therapy products are generating encouraging clinical and pre-clinical results.
Pluripotent stem cell (PSC) derived therapies, in particular, have substantial momentum and …

Transplantation of mesenchymal stem cells (MSC) improves functional recovery in
experimental models of spinal cord injury (SCI); however, the mechanisms underlying this …

As significant advancements in technology focused on Organ-on-a-chip continue, it is
feasible to consider the future of Body-on-a-chip technology. With serious work being done …

Spinal Cord Injury (SCI) causes irreversible functional loss of the affected population. The
incidence of SCI keeps increasing, resulting in huge burden on the society. The …

Spinal cord injury (SCI) is a common, severe damage to the central nervous system. Here,
we discuss the use of biomaterials for stem cell transplantation in preclinical and clinical …

Regeneration of injuries occurring in the central nervous system, particularly spinal cord
injuries (SCIs), is extremely difficult. The complex pathological events following a SCI often …

Background Spinal cord injury (SCI) is a neurological condition which paralyses the patient
below the level of injury and could occur due to damage, infection and tumors. Presently …

Since several years, adult/perinatal mesenchymal and neural crest stem cells have been
widely used to help experimental animal to recover from spinal cord injury. More …